News
-
-
-
PRESS RELEASE
CHIFFRE D'AFFAIRES DU 1er TRIMESTRE 2024 : 94,2 M EUR , EN LIGNE AVEC LES ATTENTES - CONFIRMATION DE l'AMBITION 2024 - SIGNATURE D'UNE LETTRE D'INTENTION POUR LE RACHAT DE DEUX MAGASINS FRANCHISÉS AU CANADA
Roche Bobois SA enregistre un chiffre d'affaires de 94,2 M€ au 1er trimestre 2024, confirmant ses ambitions. Signature d'une lettre d'intention pour le rachat de deux magasins franchisés au Canada -
PRESS RELEASE
Q1 2024 REVENUE: EUR 94.2M, IN LINE WITH EXPECTATIONS - 2024 AMBITIONS CONFIRMED - LETTER OF INTENT SIGNED TO ACQUIRE TWO FRANCHISED STORES IN CANADA
Roche Bobois SA posts Q1 2024 revenue of €94.2M in line with expectations. Ambitions confirmed for 2024 with a letter of intent signed to acquire two franchised stores in Canada -
-
-
-
PRESS RELEASE
EPIC Suisse AG – Annual General Meeting approves all proposals by the Board of Directors
EPIC Suisse AG's Annual General Meeting in Zurich approves all proposals by the Board of Directors with high shareholder attendance and voting support. Dividend of CHF 3.10 per share approved for 2023 -
-
PRESS RELEASE
CliniOps Awarded Patent for an Innovative Offline/Online eSource, or Direct Data Collection (DDC) System, for Global Clinical Trials
CliniOps, Inc. introduces a custom platform for clinical trials in Africa & LMICs, receiving a patent for offline data collection innovation. CEO Avik Pal & CTO Yerramalli Subramaniam as inventors